Medicaid

Press Release: Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1 diabetes

Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1...

RevelAi Health Selected for the CMS ACCESS Model, Bringing AI-Enabled Bone, Joint, and Behavioral Health Care to Medicare Beneficiaries in All 50 States

MSK Access platform pairs a bone and joint health coach and 24/7 AI-guided home exercise with behavioral health support from...

Press Release: Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy

Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy Paris, June 10, 2026. Sanofi today...

Black Book Research Releases 2026 Hospital RCM Evaluation, Naming Top Vendors Across 49 Revenue Cycle Management Categories

New category-level framework replaces broad vendor scorecards with workflow-specific, provider-validated RCM rankings for hospital finance, revenue cycle, patient access, claims,...

Revenue Cycle Management’s Boardroom Moment: AI Governance, Payer Intelligence and Cash Control Define the Next Hospital Finance Agenda Ahead of HFMA

Black Book Research releases 2026 provider-user RCM trends ahead of HFMA Annual Conference 2026, showing hospitals and health systems moving...

Regeneron to Highlight Progress Across Its Metabolic Disease, Ophthalmology and Rare Disease Pipelines at ADA and ENDO

Latest clinical data and research illustrate Regeneron’s advancement of innovative science for diverse and serious diseases with significant unmet needsTARRYTOWN,...

error: Content is protected !!